Annual Cash & Cash Equivalents
$3.50 B
-$765.41 M-17.95%
31 December 2023
Summary:
GSK annual cash & cash equivalents is currently $3.50 billion, with the most recent change of -$765.41 million (-17.95%) on 31 December 2023. During the last 3 years, it has fallen by -$2.00 billion (-36.38%). GSK annual cash & cash equivalents is now -66.95% below its all-time high of $10.58 billion, reached on 31 December 2009.GSK Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$4.27 B
+$525.23 M+14.02%
30 September 2024
Summary:
GSK quarterly cash and cash equivalents is currently $4.27 billion, with the most recent change of +$525.23 million (+14.02%) on 30 September 2024. Over the past year, it has increased by +$773.44 million (+22.11%). GSK quarterly cash and cash equivalents is now -71.97% below its all-time high of $15.24 billion, reached on 31 March 2015.GSK Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GSK Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +22.1% |
| 3 y3 years | -36.4% | -22.3% |
| 5 y5 years | -40.8% | -27.7% |
GSK Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -36.4% | at low | -70.3% | +22.1% |
| 5 y | 5 years | -57.9% | at low | -70.3% | +22.1% |
| alltime | all time | -67.0% | +9347.2% | -72.0% | >+9999.0% |
GSK Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $4.27 B(+14.0%) |
| June 2024 | - | $3.75 B(+6.4%) |
| Mar 2024 | - | $3.52 B(+0.7%) |
| Dec 2023 | $3.50 B(-18.0%) | $3.50 B(-9.8%) |
| Sept 2023 | - | $3.88 B(-2.1%) |
| June 2023 | - | $3.96 B(+10.7%) |
| Mar 2023 | - | $3.58 B(-16.0%) |
| Dec 2022 | $4.26 B(-22.5%) | $4.26 B(+5.9%) |
| Sept 2022 | - | $4.03 B(-48.6%) |
| June 2022 | - | $7.84 B(-45.6%) |
| Mar 2022 | - | $14.41 B(+162.0%) |
| Dec 2021 | $5.50 B(-33.8%) | $5.50 B(+18.6%) |
| Sept 2021 | - | $4.64 B(-4.4%) |
| June 2021 | - | $4.85 B(-25.9%) |
| Mar 2021 | - | $6.54 B(-21.2%) |
| Dec 2020 | $8.30 B(+40.5%) | $8.30 B(+50.7%) |
| Sept 2020 | - | $5.51 B(-45.2%) |
| June 2020 | - | $10.05 B(+70.4%) |
| Mar 2020 | - | $5.90 B(-0.2%) |
| Dec 2019 | $5.91 B(+20.2%) | $5.91 B(+11.7%) |
| Sept 2019 | - | $5.29 B(+1.3%) |
| June 2019 | - | $5.22 B(-3.0%) |
| Mar 2019 | - | $5.39 B(+9.6%) |
| Dec 2018 | $4.92 B(-5.1%) | $4.92 B(-0.5%) |
| Sept 2018 | - | $4.94 B(-6.6%) |
| June 2018 | - | $5.29 B(-5.7%) |
| Mar 2018 | - | $5.61 B(+8.3%) |
| Dec 2017 | $5.18 B(-13.9%) | $5.18 B(-18.7%) |
| Sept 2017 | - | $6.37 B(+22.8%) |
| June 2017 | - | $5.19 B(-7.8%) |
| Mar 2017 | - | $5.63 B(-6.5%) |
| Dec 2016 | $6.02 B(-30.3%) | $6.02 B(+0.6%) |
| Sept 2016 | - | $5.98 B(-3.2%) |
| June 2016 | - | $6.18 B(-2.5%) |
| Mar 2016 | - | $6.34 B(-26.6%) |
| Dec 2015 | $8.64 B(+27.9%) | $8.64 B(-3.5%) |
| Sept 2015 | - | $8.95 B(-24.5%) |
| June 2015 | - | $11.87 B(-22.1%) |
| Mar 2015 | - | $15.24 B(+125.7%) |
| Dec 2014 | $6.75 B(-26.0%) | $6.75 B(+1.3%) |
| Sept 2014 | - | $6.67 B(+23.7%) |
| June 2014 | - | $5.39 B(-7.9%) |
| Mar 2014 | - | $5.85 B(-35.9%) |
| Dec 2013 | $9.13 B(+35.0%) | $9.13 B(+73.6%) |
| Sept 2013 | - | $5.26 B(+21.3%) |
| June 2013 | - | $4.33 B(-25.6%) |
| Mar 2013 | - | $5.82 B(-13.9%) |
| Dec 2012 | $6.76 B(-23.2%) | $6.76 B(+22.9%) |
| Sept 2012 | - | $5.50 B(-52.0%) |
| June 2012 | - | $11.46 B(+27.5%) |
| Mar 2012 | - | $8.99 B(+2.1%) |
| Dec 2011 | $8.80 B(-5.8%) | $8.80 B(+4.3%) |
| Sept 2011 | - | $8.44 B(-10.1%) |
| June 2011 | - | $9.40 B(-10.0%) |
| Mar 2011 | - | $10.44 B(+11.7%) |
| Dec 2010 | $9.35 B | $9.35 B(-5.0%) |
| Sept 2010 | - | $9.84 B(+0.1%) |
| June 2010 | - | $9.82 B(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $10.57 B(-0.1%) |
| Dec 2009 | $10.58 B(+28.5%) | $10.58 B(+2.3%) |
| Sept 2009 | - | $10.35 B(+17.6%) |
| June 2009 | - | $8.80 B(-1.4%) |
| Mar 2009 | - | $8.92 B(+8.4%) |
| Dec 2008 | $8.24 B(+22.6%) | $8.24 B(-10.2%) |
| Sept 2008 | - | $9.17 B(-7.7%) |
| June 2008 | - | $9.94 B(+133.4%) |
| Mar 2008 | - | $4.26 B(-36.6%) |
| Dec 2007 | $6.72 B(+71.1%) | $6.72 B(+60.3%) |
| Sept 2007 | - | $4.19 B(+10.2%) |
| June 2007 | - | $3.80 B(-2.4%) |
| Mar 2007 | - | $3.90 B(-0.7%) |
| Dec 2006 | $3.93 B(-45.8%) | $3.93 B(-10.5%) |
| Sept 2006 | - | $4.39 B(-37.2%) |
| June 2006 | - | $6.99 B(-15.1%) |
| Mar 2006 | - | $8.23 B(+13.8%) |
| Dec 2005 | $7.24 B(+52.9%) | $7.24 B(-32.7%) |
| Sept 2005 | - | $10.75 B(+11.8%) |
| June 2005 | - | $9.61 B(+83.5%) |
| Mar 2005 | - | $5.24 B(+10.7%) |
| Dec 2004 | $4.73 B(+175.4%) | $4.73 B(+16.4%) |
| Sept 2004 | - | $4.07 B(-11.6%) |
| June 2004 | - | $4.60 B(+63.6%) |
| Mar 2004 | - | $2.81 B(+63.7%) |
| Dec 2003 | $1.72 B(+1.3%) | $1.72 B(-38.1%) |
| Sept 2003 | - | $2.78 B(+4.5%) |
| June 2003 | - | $2.66 B(+86.5%) |
| Mar 2003 | - | $1.42 B(-16.0%) |
| Dec 2002 | $1.70 B(+63.1%) | $1.70 B(+29.1%) |
| Sept 2002 | - | $1.31 B(-23.7%) |
| June 2002 | - | $1.72 B(+29.4%) |
| Mar 2002 | - | $1.33 B(+28.0%) |
| Dec 2001 | $1.04 B(-45.7%) | $1.04 B(-40.2%) |
| Sept 2001 | - | $1.74 B(+32.2%) |
| June 2001 | - | $1.31 B(-46.7%) |
| Mar 2001 | - | $2.47 B(+29.0%) |
| Dec 2000 | $1.91 B(+445.5%) | $1.91 B(+170.2%) |
| Sept 2000 | - | $708.02 M(-4.8%) |
| June 2000 | - | $743.56 M(-18.0%) |
| Mar 2000 | - | $906.62 M(+158.6%) |
| Dec 1999 | $350.65 M(-11.7%) | $350.65 M(-15.0%) |
| June 1999 | - | $412.65 M(+4.0%) |
| Dec 1998 | $396.94 M(+11.5%) | $396.94 M(+11.3%) |
| June 1998 | - | $356.77 M(+0.2%) |
| Dec 1997 | $356.06 M(-19.7%) | $356.06 M(-19.7%) |
| Dec 1996 | $443.57 M(+22.7%) | $443.57 M(+270.3%) |
| Dec 1995 | $361.43 M(+201.7%) | - |
| June 1995 | - | $119.79 M(+41.4%) |
| June 1995 | $119.79 M(+41.4%) | - |
| June 1994 | $84.73 M(-10.9%) | $84.73 M(-10.9%) |
| June 1993 | $95.05 M(+108.4%) | $95.05 M(+108.4%) |
| June 1992 | $45.60 M(-17.3%) | $45.60 M(-17.3%) |
| June 1991 | $55.16 M(-88.1%) | $55.16 M(-88.1%) |
| June 1990 | $463.64 M(-48.0%) | $463.64 M(-48.0%) |
| June 1989 | $891.14 M(+1203.7%) | $891.14 M(+1203.7%) |
| June 1988 | $68.35 M(+84.6%) | $68.35 M(+84.6%) |
| June 1987 | $37.03 M(-30.9%) | $37.03 M(-30.9%) |
| June 1986 | $53.57 M | $53.57 M |
FAQ
- What is GSK annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for GSK?
- What is GSK quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for GSK?
- What is GSK quarterly cash and cash equivalents year-on-year change?
What is GSK annual cash & cash equivalents?
The current annual cash & cash equivalents of GSK is $3.50 B
What is the all time high annual cash & cash equivalents for GSK?
GSK all-time high annual cash & cash equivalents is $10.58 B
What is GSK quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of GSK is $4.27 B
What is the all time high quarterly cash and cash equivalents for GSK?
GSK all-time high quarterly cash and cash equivalents is $15.24 B
What is GSK quarterly cash and cash equivalents year-on-year change?
Over the past year, GSK quarterly cash and cash equivalents has changed by +$773.44 M (+22.11%)